Here are Morgan Stanley’s key oncology catalysts for 2025
Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...
bovnews36m
ING’s Unexpected Plunge: What’s Next?
Morgan Stanley has recently reduced ING Groep NV (ING) stock rating, as announced on November 26, 2024, according to Finviz. Earlier, on October 22, 2024, Barclays had reduced the stock from a ...